These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Design, Synthesis and Anticancer Profile of New 4-(1 Abdel-Maksoud MS; Mohamed AAB; Hassan RM; Abdelgawad MA; Chilingaryan G; Selim S; Abdel-Bakky MS; Al-Sanea MM Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638829 [TBL] [Abstract][Full Text] [Related]
45. In Silico Screening and Anticancer-Apoptotic Evaluation of Newly Synthesized Thienopyrimidine/Sulfonamide Hybrids. Elmongy EI; Binjubair FA; Alshehri OY; Baeshen KA; Almukhalfi ZA; Henidi HA Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446005 [TBL] [Abstract][Full Text] [Related]
46. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2. Alkahtani HM; Abdalla AN; Obaidullah AJ; Alanazi MM; Almehizia AA; Alanazi MG; Ahmed AY; Alwassil OI; Darwish HW; Abdel-Aziz AA; El-Azab AS Bioorg Chem; 2020 Jan; 95():103461. PubMed ID: 31838290 [TBL] [Abstract][Full Text] [Related]
47. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents. Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492 [TBL] [Abstract][Full Text] [Related]
48. Design, synthesis and antiproliferative activity of the new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors. Kamal A; Ashraf M; Basha ST; Ali Hussaini SM; Singh S; Vishnuvardhan MV; Kiran B; Sridhar B Org Biomol Chem; 2016 Jan; 14(4):1382-94. PubMed ID: 26676480 [TBL] [Abstract][Full Text] [Related]
49. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition. Maher M; Kassab AE; Zaher AF; Mahmoud Z Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080 [TBL] [Abstract][Full Text] [Related]
50. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent. Noolvi MN; Patel HM; Bhardwaj V; Chauhan A Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891 [TBL] [Abstract][Full Text] [Related]
51. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents. Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446 [TBL] [Abstract][Full Text] [Related]
52. Anticancer profile and anti-inflammatory effect of new N-(2-((4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine sulfonamide derivatives. Abdel-Maksoud MS; Mohamed Hassan R; Abdel-Sattar El-Azzouny A; Nabil Aboul-Enein M; Oh CH Bioorg Chem; 2021 Dec; 117():105424. PubMed ID: 34678604 [TBL] [Abstract][Full Text] [Related]
53. Synthesis, Anticancer and Antitubercular Properties of New Chalcones and Their Nitrogen-Containing Five-Membered Heterocyclic Hybrids Bearing Sulfonamide Moiety. Castaño LF; Quiroga J; Abonia R; Insuasty D; Vidal OM; Seña R; Rubio V; Puerto G; Nogueras M; Cobo J; Guzman J; Insuasty A; Insuasty B Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293443 [TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and evaluation of novel (S)-tryptamine derivatives containing an allyl group and an aryl sulfonamide unit as anticancer agents. Guo Z; Xu Y; Peng Y; Haroon Ur Rashid ; Quan W; Xie P; Wu L; Jiang J; Wang L; Liu X Bioorg Med Chem Lett; 2019 May; 29(9):1133-1137. PubMed ID: 30842032 [TBL] [Abstract][Full Text] [Related]
56. Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives. Tiwari SV; Siddiqui S; Seijas JA; Vazquez-Tato MP; Sarkate AP; Lokwani DK; Nikalje APG Molecules; 2017 Jun; 22(6):. PubMed ID: 28617341 [TBL] [Abstract][Full Text] [Related]
57. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents. Hao S; Cheng X; Wang X; An R; Xu H; Guo M; Li C; Wang Y; Hou Z; Guo C Bioorg Chem; 2020 Nov; 104():104237. PubMed ID: 32911194 [TBL] [Abstract][Full Text] [Related]
58. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors. El-Sherief HAM; Youssif BGM; Abbas Bukhari SN; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM Eur J Med Chem; 2018 Aug; 156():774-789. PubMed ID: 30055463 [TBL] [Abstract][Full Text] [Related]
59. Design, synthesis, in vitro anticancer evaluation, kinase inhibitory effects, and pharmacokinetic profile of new 1,3,4-triarylpyrazole derivatives possessing terminal sulfonamide moiety. Abdel-Maksoud MS; El-Gamal MI; Gamal El-Din MM; Oh CH J Enzyme Inhib Med Chem; 2019 Dec; 34(1):97-109. PubMed ID: 30362383 [TBL] [Abstract][Full Text] [Related]